ANTX
AN2 Therapeutics, Inc.
$4.42
-0.28 (-5.96%)
At close · Jul 2
Market Cap
$159.19M
Shares
36,016,161
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
77/100
Short interest 3.6% of shares — P64
Days to cover 6.9 — P83
Short-volume trend +11.5% — P84
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-15). Equal-weight mean of the available factors.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-15 | 1,305,874 | 1,207,503 | +98,371 | 6.91 |
| 2026-05-29 | 1,207,503 | 836,372 | +371,131 | 5.39 |
| 2026-05-15 | 836,372 | 879,488 | -43,116 | 3.47 |
| 2026-04-30 | 879,488 | 633,935 | +245,553 | 3.31 |
| 2026-04-15 | 633,935 | 564,275 | +69,660 | 1.52 |
| 2026-03-31 | 564,275 | 711,585 | -147,310 | 1.39 |
| 2026-03-13 | 711,585 | 58,207 | +653,378 | 1.00 |
| 2026-02-27 | 58,207 | 53,144 | +5,063 | 1.00 |
| 2026-02-13 | 53,144 | 52,574 | +570 | 1.00 |
| 2026-01-30 | 52,574 | 50,000 | +2,574 | 1.00 |
| 2026-01-15 | 50,000 | 44,898 | +5,102 | 1.00 |
| 2025-12-31 | 44,898 | 41,353 | +3,545 | 1.00 |
| 2025-12-15 | 41,353 | 37,586 | +3,767 | 1.00 |
| 2025-11-28 | 37,586 | 47,530 | -9,944 | 1.00 |
| 2025-11-14 | 47,530 | 38,130 | +9,400 | 1.00 |
| 2025-10-31 | 38,130 | 40,679 | -2,549 | 1.00 |
| 2025-10-15 | 40,679 | 67,864 | -27,185 | 1.00 |
| 2025-09-30 | 67,864 | 58,758 | +9,106 | 1.00 |
| 2025-09-15 | 58,758 | 30,463 | +28,295 | 1.00 |
| 2025-08-29 | 30,463 | 15,217 | +15,246 | 1.00 |
| 2025-08-15 | 15,217 | 14,430 | +787 | 1.00 |
| 2025-07-31 | 14,430 | 33,212 | -18,782 | 1.00 |
| 2025-07-15 | 33,212 | 34,475 | -1,263 | 1.00 |
Showing 1–23 of 23 settlements